{"id":"W2088357532","doi":"10.1016/s1556-0864(15)31605-1","title":"Gefitinib (IRESSA) with Vinorelbine or Vinorelbine/Cisplatin for Chemotherapy-Naive Non-small Cell Lung Cancer Patients","year":2006,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Regional Cancer Foundation","funders":"","keywords":"Vinorelbine; Medicine; Gefitinib; Oncology; Lung cancer; Cisplatin; Chemotherapy; Vinblastine; Internal medicine; Cancer; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004736247,0.0003737797,0.001173738,0.0002656213,0.0004333344,0.0004213814,0.0003730244,0.0006002131,0.002913059],"category_scores_gemma":[0.001021636,0.0001679004,0.001030054,0.0002964897,0.0002364343,0.0006540907,0.0001433412,0.0009035346,0.0003136673],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008266345,"about_ca_system_score_gemma":0.0008323015,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002196274,"about_ca_topic_score_gemma":0.01003165,"domain_scores_codex":[0.9997759,0.00006405183,0.0000206033,0.00004489292,0.00002283202,0.00007156116],"domain_scores_gemma":[0.9997228,0.00007505292,0.00004902887,0.00001606241,0.00001242788,0.0001247196],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2177096,0.005704451,0.1877704,0.00093463,0.002168205,0.003872423,0.0003738739,0.005980349,0.02606406,0.0007894188,0.01606461,0.532568],"study_design_scores_gemma":[0.05427276,0.1078373,0.7895235,0.0002097621,0.003295753,0.007852153,0.0003582669,0.006723117,0.00885997,0.001288382,0.01964568,0.0001333047],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9897655,0.004694038,0.0001419061,0.001107684,0.000175692,0.0001167534,0.0002919198,0.00004957818,0.003656996],"genre_scores_gemma":[0.9974686,0.001006573,0.0002156273,0.0002241737,0.0001055915,0.0000385588,0.0003315854,0.000004553971,0.0006047667],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002913059,"threshold_uncertainty_score":0.009745121,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01251590649238563,"score_gpt":0.3944711770996512,"score_spread":0.3819552706072656,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}